The emerging therapy of tirzepatide peptide represents a major development in the handling of the condition. Unlike existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatide-peptide849979.rimmablog.com/40768462/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment